Welcome
Support Centre
12 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
A randomised controlled study of mouth swab testing versus same-day blood tests for human immunodeficiency virus (HIV) infection in young people attending a young person's community drug service
Source of recordUK Trials
ISRCTNISRCTN38526137
Date ISRCTN assigned06/02/2008
Local reference number(s)196AA
Public titleA randomised controlled study of mouth swab testing versus same-day blood tests for human immunodeficiency virus (HIV) infection in young people attending a young person's community drug service
Scientific title
AcronymN/A
Disease/condition/study domainSexually transmitted infections/HIV
Study hypothesisThe objective is to determine if providing an oral swab test in the community for blood borne virus testing leads to an increase in subsequent attendance for sexually transmitted infection screening at the Genito Urinary Medicine (GUM) clinic compared to making appointments for young people to attend the clinic for same day HIV testing and sexually transmitted infections (STI) screening.
Design/methodologySingle-centre randomised controlled trial
Research ethics reviewEthics approval received from the Leicestershire, Northamptonshire and Rutland Research Ethics Committee (REC) on the 16th January 2007 (ref: 06/Q2501/244).
Countries of trialUnited Kingdom
Participants - inclusion criteriaAll young people (under 18 years, male and female) engaged with the young person's substance misuse service deemed competent to provide informed consent.
Participants - exclusion criteriaAll young people engaged with the young person's substance misue service who are deemed not competent to provide informed consent.
Patient information material
Anticipated start date01/04/2007
Anticipated end date31/03/2008
Status of trialCompleted
Target number of participants54
InterventionsControl group:
Participants will have a discussion about HIV; they will then be offered an appointment at the GUM clinic. If they agree to an appointment they will be referred to the same-day HIV testing service carried out at the GUM clinic. Here they will be offered blood tests for syphilis, HIV, Hepatitis B and C as per clinic protocol and offered screening tests for genital infections (chlamydia, gonorrhoea and trichomonas). This is the approach which is currently used at the community drug service.

Study group:
Participants will have a pre-test discussion about HIV; they will then be offered an oral swab test for HIV, Hepatitis B and Hepatitis C. The swab tests are sent to the lab for processing with results available in 48 hours. Participants will also be offered an appointment at the Genito Urinary Medicine Clinic for screening tests for genital infections. Negative mouth swab results will result in advice and support regarding sexual health and harm minimisation regarding substance misuse. Positive mouth swab results will result in fast-track referral to the GUM clinic.
Primary outcome measure(s)The number of individuals attending the Genito Urinary Medicine clinic for screening tests.
Secondary outcome measure(s)1. The number of unvaccinated study participants receiving at least one dose of Hepatitis A and B vaccination
2. The number of unvaccinated study participants receiving 3 doses of the rapid Hepatitis A and B vaccination
3. The number of participants receiving results within a week of testing
Sources of fundingGilead Sciences Ltd (UK)
Sponsor nameDerbyshire Mental Health Services NHS Trust (UK)
Sponsor detailsBramble House
Kingsway
Derby
United Kingdom
DE22 3LZ
Sponsor websitehttp://www.derbyshirementalhealthservices.nhs.uk/
Contact nameDr Ade Apoola
Contact detailsGenito-Urinary Medicine Clinic
Derbyshire Royal Infirmary
London Road
Derby
United Kingdom
DE1 2QY
Contact emailade.apoola@derbyhospitals.nhs.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN38526137
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central